 CAMBRIDGE, Mass., May 17, 2022 GLOBE NEWSWIRE -- Oncorus, Inc. Nasdaq: ONCR, a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today announced that President and Chief Executive Officer, Theodore Ted Ashburn, M.D., Ph.D., will present an update on the Companys progress at the H.C. Wainwright Global Investment Conference. The presentation will be available for on-demand viewing starting Tuesday, May 24, 2022 at 7:00 a.m. ET. 